Health and Wellness Deals Galore this October with Reckitt Indonesia’s Lazada Super Brand Day
JAKARTA, Indonesia, Oct. 21, 2022 /PRNewswire/ -- As the world relaxes protocols against Covid-19, the fight against germs is far from over. From individuals to families, good health is strongly correlated with good hygiene and nutrition. According to the World Bank, hygiene promotion is the most cost-effective health action to reduce disease. However, ensuring better hygiene in the home...
MGI Contributes to Thailand’s Roadmap for Genomic Medicine in Genomics Thailand Initiative
BANGKOK, Oct, 21 2022 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the supply of its products* to support the sequencing of the genomes of 50,000 Thai individuals as part of the Genomics Thailand Initiative, which focuses on increasing the country's competitiveness in genomic...
Akeso’s Ivonescimab (PD-1/VEGF BsAbs) Granted Breakthrough Therapy Designation by China NMPA for the Treatment of Advanced NSCLC
HONG KONG, Oct. 21, 2022 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso"), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, announced that the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD)...
IMG Announces 2022 Leave Your Mark Contest Winners
INDIANAPOLIS, Oct. 20, 2022 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning global insurance benefits and assistance services company, is excited to announce the winners of its sixth annual Leave Your Mark contest: Forward Edge International, Advocates of Love, and Dare for More. The winning organizations will receive $5,000, $3,000, and $2,000...
132nd Canton Fair Gives Full Play to the Advantages of China’s Medical and Health Industry to Provide Quality Health Care Choices
GUANGZHOU, China, Oct. 20, 2022 /PRNewswire/ -- The 132nd Canton Fair, which started on October 15th, 2022, gathers leading companies from China's health industr -- giving full play to its industry advantages and while providing global consumers with better health care choices. Among them, Crown Name (WH) Disposable Hygiene Products ("Crown Name") presents its medical, industrial safety protection, and...
Official Ground-breaking Ceremony of Wuhan Synthetic Biology Innovation Center & CABIO R&D Center Investment Project
WUHAN, China, Oct. 20, 2022 /PRNewswire/ -- On October 19th, 2022, the investment project of the CABIO R&D Center officially commenced in Wuhan Optical Valley. Upon the basis of the said investment project, the ground-breaking ceremony of the "Wuhan Synthetic Biology Innovation Center" project, a joint endeavor between CABIO Biotech (Wuhan) Co., Ltd, the Wuhan Institute of Industrial Innovation and...
AUM Biosciences and Asymchem Complete Phase II API Production Campaign of Novel TRK Inhibitor
TEDA TIANJIN, P.R. China and SINGAPORE, Oct. 20, 2022 /PRNewswire/ -- Asymchem (stock code: 002821.SZ), a leading global contract development and manufacturing service provider, and AUM Biosciences (AUM), a global clinical stage biotech company, focused on discovering, acquiring and developing next generation targeted oncology therapeutics, jointly announced today the completion of their first GMP production...
Grand Opening of ‘Medlab Asia & Asia Health 2022’ in Thailand
BANGKOK, Oct. 20, 2022 /PRNewswire/ -- Thailand's Minister of Public Health officiates Medlab Asia & Asia Health 2022, the leading trade exhibition within the medical laboratory industry in the ASEAN region, organised by Informa Markets and IMPACT Exhibition Management, attracting over 11,000 participants, expected to generate business over 700 million Baht. Wouter Molman, Executive...
Harbour BioMed Announces Dosing of First Patient in Phase I Trial of B7H4x4-1BB Bispecific Antibody in the United States
CAMBRIDGE, Mass., ROTTERDAM and SUZHOU, China, Oct. 20, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, it has successfully completed the dosing of first patient in the global phase I trial of B7H4x4-1BB bispecific antibody HBM7008 in the United States. This study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary...
BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing
BRISBANE, Australia, Oct. 20, 2022 /PRNewswire/ -- BGI Australia's lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing in Australia, paving the way for the global life sciences company to provide clinical sequencing services for identifying possible disease-causing genetic changes. The lab will start to provide clinical services in Australia for the...
